How effective is Flow Treatment?

In the clinical trial that supported FDA approval, after 10 weeks:

• 57.5% of people using Flow Treatment had very few or no symptoms of depression left, compared with 29.4% of people using the sham device.*
• 64.2% saw their symptoms at least halve, compared with 32.3% using the sham device. 

A second depression scale was also used (HDRS), on which 44.9% reached remission compared with 21.8%. 

The trial included 174 adults with moderate to severe major depressive disorder, some using Flow Treatment on its own and some alongside other depression treatment. Half used an active headset and half used one that looked and felt identical but delivered no treatment, so the two groups could be compared fairly. 

You can read the study here: Home-based transcranial direct current stimulation treatment for major depressive disorder: a fully remote phase 2 randomized sham-controlled trial

Flow Treatment does not work for everyone, and there is a risk it will not work for you. Your clinician can help you weigh whether it is worth trying.

*Measured on the Montgomery-Asberg Depression Rating Scale. Remission was defined as a score of 10 or less.